IPO - Qualigen Therapeutics, Inc.

Form Type: CORRESP

Filing Date: 2024-12-17

Corporate Action: Ipo

Type: New

Accession Number: 000149315224050406

Filing Summary: Qualigen Therapeutics, Inc. submitted a request to accelerate the effective date of its registration statement on Form S-1. The company is seeking for the registration statement to become effective on December 19, 2024, at 4:00 p.m. Eastern Time. The request indicates the company is preparing for an initial public offering and acknowledges its obligations under the Securities Act of 1933. The company has requested notification of the effectiveness by contacting their legal counsel, Sichenzia Ross Ference Carmel LLP.